# ResMed (RMD) — News

RMD · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/rmd/news

## Recent headlines

- [Raiz Invest - Board directed remediation program commenced](https://www.ainvest.com/news/raiz-invest-board-directed-remediation-program-commenced-2610) — AInvest Wire, Oct 12, 2026
  Raiz Invest Limited (ASX: RZI) has announced the commencement of a board-directed remediation program aimed at addressing governance and compliance concerns raised by regulatory authorities. The initiative follows a review of internal controls and processes, with the goal of aligning the company’s…
- [ResMed Inc.: RBC raises to outperform from sector perform; raises target price to $262 from $244](https://www.ainvest.com/news/resmed-rbc-raises-outperform-sector-perform-raises-target-price-262-244-2609) — AInvest Wire, Sep 15, 2026
  RBC Capital Markets has upgraded its rating for ResMed Inc. (RMD) from "sector perform" to "outperform," reflecting a more positive outlook on the company's prospects. The firm also raised its target price for the stock to $262 from $244, indicating increased confidence in ResMed's future…
- [Resmed Inc. - Accelerated share repurchase agreement announcement](https://www.ainvest.com/news/resmed-accelerated-share-repurchase-agreement-announcement-2609) — AInvest Wire, Sep 1, 2026
  ResMed Inc. (NYSE: RMD) has entered into an accelerated share repurchase (ASR) agreement with Citibank, N.A. to repurchase $450.0 million of its common stock. The ASR, announced on August 31, 2026, is part of the company’s broader share repurchase authorization of 20,000,000 shares, which was…
- [ResMed - Final settlement of ASR agreement scheduled for December 2026 - SEC filing](https://www.ainvest.com/news/resmed-final-settlement-asr-agreement-scheduled-december-2026-sec-filing-2609) — AInvest Wire, Sep 1, 2026
- [Resmed - Enters accelerated share repurchase agreement to repurchase $450 mln of common stock - SEC filing](https://www.ainvest.com/news/resmed-enters-accelerated-share-repurchase-agreement-repurchase-450-mln-common-stock-sec-filing-2609) — AInvest Wire, Sep 1, 2026
  ResMed Inc. (NYSE: RMD) has announced plans to repurchase $450 million of common stock through an accelerated share repurchase (ASR) program, as disclosed in a recent SEC filing. The company intends to utilize a portion of the proceeds from the sale of its MatrixCare business, which was agreed upon…

## Similar Stocks

- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [HIMS](https://www.lighthorse.io/tickers/hims) — Hims & Hers Health, Inc. Class A Common Stock
- [EHC](https://www.lighthorse.io/tickers/ehc) — Encompass Health Corporation Common Stock

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).